NIG
RMD icon

NFJ Investment Group’s ResMed RMD Stock Holding History

NFJ Investment Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-55
Closed -$15.1K – 284
2025
Q3 		$15.1K Sell
55
-5,332
-99% -$1.46M ﹤0.01% 236
2025
Q2 		$1.39M Buy
+5,387
New +$1.29M 0.05% 228
2022
Q3 		– Sell
-100,585
Closed -$21.1M – 345
2022
Q2 		$21.1M Sell
100,585
-3,291
-3% -$701K 0.5% 67
2022
Q1 		$25.2M Sell
103,876
-3,202
-3% -$775K 0.51% 61
2021
Q4 		$27.9M Buy
107,078
+45,478
+74% +$11.8M 0.51% 59
2021
Q3 		$16.2M Sell
61,600
-55,909
-48% -$15.3M 0.32% 93
2021
Q2 		$29M Buy
117,509
+21,437
+22% +$4.51M 0.55% 51
2021
Q1 		$18.6M Buy
+96,072
New +$19.3M 0.37% 85

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NFJ Investment Group's RMD Position: Q4 2025 in Review

NFJ Investment Group sold out of ResMed (RMD) in Q4 2025, closing a stake of 55 shares — an estimated $15.1K sold.

NFJ Investment Group first reported a position in RMD in Q1 2021 and held it in 8 quarters. The position peaked at $29M in Q2 2021. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • NFJ Investment Group reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • NFJ Investment Group sold 55 ResMed shares in Q4 2025, an estimated $15.1K.
  • NFJ Investment Group first reported a position in ResMed in Q1 2021 and held it in 8 quarters.
  • NFJ Investment Group's ResMed position peaked at $29M in Q2 2021.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on NFJ Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.